Carbamylated erythropoietin (CEPO), a well characterized erythropoietin (EPO) del'ivative, does not bind to the classical EPO receptor and does not stimulate erythropoiesis. Using neural progenitor cells derived from the subventricular zone of the adult mouse, we investigated the effect of CEPO on neurogenesis and the associated signaling pathways in vitro. We found that CEPO significantly increased neural progenitor cell prolifel'ation a~d promoted neural progenitor cell differentiation into neurons, which was associated with up-regulation of Sonic hedgehog (Shh), its receptor pte, and mammalian achaete-scute homolog 1 (Mash1), a pro-neuron basic helix-loop-helix protein transcription factor. Blockage ofthe Shh signaling pathway with a pharmacological inhibitor, cyclopamine, abolished the CEPOinduced neurogenesis. Attenuation of endogenous Mashl expression by short-interfering RNA blocked CEPO-promoted neuronal differentiation. In addition, recombinant mouse Shh up-l'egulated Mashl expression in neural progenitor cells. These results demonstrate that the Shh signaling pathway mediates CEPO-enhanced neurogenesis and Mashl is a downstream target of the Shh signaling pathway that regulates CEPO-enhanced neuronal differentiation.
that CEPO significantly increased neural progenitor cell prolifel'ation a~d promoted neural progenitor cell differentiation into neurons, which was associated with up-regulation of Sonic hedgehog (Shh), its receptor pte, and mammalian achaete-scute homolog 1 (Mash1), a pro-neuron basic helix-loop-helix protein transcription factor. Blockage ofthe Shh signaling pathway with a pharmacological inhibitor, cyclopamine, abolished the CEPOinduced neurogenesis. Attenuation of endogenous Mashl expression by short-interfering RNA blocked CEPO-promoted neuronal differentiation. In addition, recombinant mouse Shh up-l'egulated Mashl expression in neural progenitor cells. These results demonstrate that the Shh signaling pathway mediates CEPO-enhanced neurogenesis and Mashl is a downstream target of the Shh signaling pathway that regulates CEPO-enhanced neuronal differentiation.
Ischemic stroke induces neurogenesis (1) (2) (3) (4) . Erythropoietin (EPO)2 has neuroprotective effects for treatment of acute stroke via interaction with its receptor (EPOR) (5) . Recent studies show that EPO increases neurogenesis in the subventricular zone (SVZ) of adult rodent brain under normal and stroke conditions via interaction with EPOR (6 -8) . Systemic administra- 2 The abbreviations used are: EPO, erythropoietin; EPOR, EPO receptor; CEPO, carbamylated EPO; SVZ, subventricular zone; Shh, Sonic hedgehog; EGF, epidermal growth factor; bFGF, basic fibroblast growth factor; BrdUrd, bromodeoxyuridine; siRNA, short interfering RNA; RT-PCR, reverse transcription PCR; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; DAPI, 4',6-diamidino-2-phenylindole.
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tion of EPO enhances stroke-induced neurogenesis (6) . However, EPO also elevates hematocrit levels, which could lead to adverse effects on stroke recovery (6, 9) . Carbamylated erythropoietin (CEPO), a non-erythropoietic derivative ofEPO that does not bind to the classical EPOR (10) , is neuroprotective for acute stroke but does not elevate hematocrit levels. The effect of CEPO on neurogenesis has not been investigated.
Sonic hedgehog (Shh) is a member of the family of the hedgehog proteins known to exert important regulatory functions in patterning and growth in a large number of tissues during embryogenesis (11) (12) (13) . In the mammalian brain, Shh plays an important role for the regulation of progenitor cell proliferation and differentiation (14) (15) (16) (17) . Shh binds to the transmembrane receptor protein patched (ptc), which, in the absence of Shh, exerts an inhibitory effect on the seven-transmembrane receptor smoothened (Smo) (18, 19) . Binding ofShh to ptc blocks the inhibitory effect of ptc on Smo. Once activated, Smo induces a complex series of intracellular reactions that target the Gli family of transcription factors (11) . Glil is the principal effector of Shh signaling in neural progenitor cells (20) . In the present study, using neural progenitor cells derived from the SVZ of adult mice, we tested the hypothesis that CEPO via Shh signaling promotes proliferation and differentiation of neural progenitor cells.
EXPERIMENTAL PROCEDURES
All experimental procedures were approved by the Institutional Animal Care and Use Committee of Henry Ford Hospital. Male mice (C57BL6/J, 6-8 weeks) were purchased from The Jackson Laboratory (Bar Harbor, ME) . EPOR null mice (6EPOR mice, C57BL6 background) were provided by Dr. Constance Tom Noguchi at NIDDK, National Institutes of Health (44) .
Neurosphere Culture-SVZ neural progenitor cells were dissociated from normal (n =:' 10) and 6EPOR mice (n = 10) as previously reported (21, 22) . The cells were plated at a density of 2 X 10 4 cells/ml in growth medium . Growth medium contains Dulbecco's modified Eagle's-F-12 medium (Invitrogen), 20 ng/ml of epidermal growth factor (EGF) (R&D Systems, Minneapolis, MN), and 20 ng/ml of basic fibroblast growth factor (bFGF) (R&D Systems). Dulbecco's modified Eagle's-F-12 medium contains L-glutamine (2 mM), glucose (0.6%), putrescine (9.6 J.Lg/ml), insulin (0.025 mg/ml), progesterone (6.3 ng/ml), apo-transferrin (0.1 mg/ml), and sodium selenite (5.2 ng/ml). The generated neurospheres (primary sphere) were passaged by mechanical dissociation and reseeded as single cells at a density of 20 cells/ J.LI in bFGF-and EGF-containing media (passage 1 cells). Passage 1 cells were processed for various experiments in the present study. These cells were cultured in reduced growth medium containing 10 ng/ml of EGF and 10 ng/ml of bFGF.
To analyze the formation of secondary neurospheres, passage 1 neurospheres were collected and digested with 0.05% trypsin-EDTA (Invitrogen) for 5 min at 37°C. They were then gently triturated with a fire-narrowed Pasteur pipette, spun down at 400 rpm for 3 min, resuspended in the reduced growth medium, and plated at 1 X 101-cells/ml in each well of a 24-well plate (Corning). The number of neurospheres was counted at 7 days in vitro.
To analyze cell proliferation, bromodeoxyuridine (BrdUrd) (20 J.Lg/ml), the thymidine analog that is incorporated into the DNA of dividing cells during S-phase was added into the reduced growth medium 18 h prior to termination of incubation. BrdUrd-positive cells were measured.
To dynamically measure dividing neural progenitor cells, time-lapse microscopy was employed (23) . Cultured neurospheres were incubated in a stage top chamber with 5% CO 2 and 37°C (LiveCeli Control Unit), which was placed on the stage of a Nikon TE2000-U inverted microscope equipped. with a motorized Z stage. A X 10 objective with X 1.5 electronic zoom was used for acquiring images. A stack of images (30 images with a 5-J.Lm step in z-axes) were acquired at IS -min intervals for a total of 20 h using a CCD camera (CoolS nap, 5000) and MetaView software (Universal Imaging, West Chester, PAl (23) .
To analyze phenotypes of neural progenitor cells, neurospheres were mechanically dissociated as single cells. These cells (2.5 X 10 4 cells/cm' ) were plated directly onto laminincoated glass coverslips in Dulbecco's modified Eagle's-F-12 medium containing 2% fetal bovine serum but without the growth factors for 7 days. This medium was referred to as the differentiation medium. Immunocytochemistry was performed with various antibodies (see below) to determine phenotypes of neural progenitor cells.
Experimental Protocol-I) To examine whether Shh/Gli signaling pathway is involved in the effects ofCEPO on neurogenesis, neural progenitor cells were incubated in the presence of CEPO (0, 1, 10, 100 ng/ml) (H. Lundbeck A/S, Denmark) with or without cyclopamine (a specific inhibitor ofSmo, 5 J.LM; Calbiochem, San Diego, CAl. Neural progenitor cell proliferation and differentiation and activation of the Shh/Gli pathway were measured. In addition, neural progenitor cells were transfected with mouse Gli1 siRNA and incubated with CEPO (10 ng/ml). 2) To examine the effects ofCEPO on Mash1 expression, neural progenitor cells were incubated in the presence of CEPO (10 ng/ml). Mashl mRNA and protein levels were measured. 3) To examine the role of Mashl on CEPO-enhanced neuronal differentiation, neural progenitor cells were transfected with mouse Mash1 siRNA cassettes and incubated with CEPO (10 ng/ml) . Neuronal differentiation and Mashllevels were measured. 4) To examine the direct effect of Shh on neural progenitor cell proliferation, differentiation, and Mash1 expression, neural progenitor cells were incubated in the presence of recombinant mouse Shh (Shh-N terminus, 0, 10, 100, 1000 ng/ml; R&D Systems) with or without cyclopamine (5 J.LM).
Mouse siRNA Synthesis and Transfection-Mouse Mash1 siRNA cassettes were designed according to the Mouse Mash1 sequence in GenBank ™ (NM_008553) using siRNA target finder (GenScript Corp., Piscataway, NJ). The selected sequences were chemically synthesized, and the cassettes were constructed by PCR, which consists of a 505-bp human HI promoter and terminator sequence flanking a DNA insert encoding a small hairpin RNA (GenScript Corp). A BLAST search against the mouse genome was performed for the specificity of all target sequences and the scrambled sequences. All cassettes were labeled at the 5' -end with Cy3 for control of transfection efficiency (Fig. 7) . Mouse Glil siRNA was purchased from Dharmacon, Inc. Neural progenitor cells were transfected using the Mouse NSC Nucleofector ™ kit (Amax Inc.) following the . manufacturer's instructions. The total amount of siRNA per transfection was kept constant to 0.5 J.Lg/ml. mRNA and protein levels were measured 48 and 72 h after transfection.
Real-time RT-PCR-Quantitative PCR was performed using the SYBR Green real-time PCR method (24) . Total RNA was isolated from neural progenitor cell cultures using the Stratagene Absolutely RNA MicroRNA isolation kit (La Jolla, CAl. Quantitative RT-PCR was performed on an ABI 7000 PCR instrument (Applied Biosystems, Foster City, CAl using threestage program parameters provided by the manufacturer, as follows; 2 min at 50°C, 10 min at 95 DC, and then 40 cycles of 15 s at 95°C and 1 min at 60 dc. Specificity of the produced amplifIcation product was confirmed by examination of dissociation reaction plots. A distinct single peak indicated that a single DNA sequence was amplified during PCR. PCR products were run on 2% agarose gels to confirm that correct molecular sizes were present. Each sample was tested in triplicate, and samples obtained from three independent experiments were used for analysis of relative gene expression using the 2-ll.ll.
CT method (25) . The following primers for real-time PCR were designed using Primer Express software (ABI) : Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (FWD, AGA ACA TCA TCC CTG CAT CC; REV, CAC ATT GGG GGT AGG AAC AC); Shh (FWD, CCT TTA CCC TAC AAG CAG TTT ATT GC; REW, GTA ATT GGG GGT GAG TTC CTT AAA TC); ptch1 (FWD, TAG CGC CTT CTT CTT TTG GA; REV, GTG GAA GTT GGT GGA CGA GT); Glil (FWD, TCC ACA CGC CCC CT A GTG; REV, TGG CAA CAT TTT CGG TGA TG); Mash1 (FWD, TCT CCT GGG AAT GGA CTT TG; REW, GGT TGG CTG TCT GGT TTG TT).
Immunocytochemistry and Quantification-Single and double immunofluorescent stainings of cultured cells were performed as previously described (2, 26) . The following primary antibodies were used in the present study: mouse anti-BrdUrd (1:100; Roche Applied Science), mouse anti-(3-tubulin III (TuJ-1, 1:500; Covance), mouse anti-microtubule-associated protein 2 (MAP2) (1 :200; Chemicon), mouse anti-NeuN (1:100; Chemicon), rabbit anti-glial fibrillary acidic protein (GFAP) (1:500; Dako Cytomation, Carpinteria, CA), rabbit anti-Glil (1 :300; Abcam Inc. Cambridge, MA), rabbit anti-nestin (1:100; BD Biosciences), rabbit anti-SOX2 (1:50; Santa Cruz Biotechnology), and mouse anti-Mash 1 monoclonal (1:250; BD Biosciences). Cultured cells were fixed in 4% paraformaldehyde for 15-20 min at room temperature. Nonspecific binding sites were blocked with 5% normal goat serum for 60 min at room temperature. The cells were then incubated with the primary antibodies listed above and with CY3-conjugated or fluorescein isothiocyanate-conjugated secondary antibodies. Nuclei were counterstained with 4',6' -diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA). The number of BrdUrd-, TuJl-, MAP2-, NeuN-, and GFAP-positive cells and total DAPI cell number were counted, and the percentage of each cell type was determined.
Western Blot Analysis-Western blots were performed according to published methods (27) . Briefly, Iysates from neural progenitor cells were sonicated for 10 s and centrifuged at 14,000 X g for 20 min. Protein concentration in the supernatants of cell extract was determined using a BCA protein assay kit (Pierce Biotechnology, Inc.). Equal amounts of proteins were loaded on 10% SDS-polyacrylamide gel. After electrophoresis, the proteins were transferred to nitrocellulose membranes, and the blots were subsequently probed with the following antibodies: Shh (N-19) (1 :200; Santa Cruz Biotechnology), patched (G -19) (1:200; Santa Cruz Biotechnology), Gli1 (1:5000; Abcam Inc.), and Mash1 (1 :250; BD Biosciences) . For detection, horseradish peroxidase-conjugated secondary antibodies were used (1:2000) followed by en hanced chemiluminescence development (Pierce). Normalization of results was ensured by running parallel Western blots with {3-actin antibody. The optical density was quantified using an image processing and analysis program (Scion Image, Ederick, MA).
Measurements of Neurite Outgrowth-To analyze neurite outgrowth, TuJl-positive cells ",ere digitized using a X 20 objective (Zeiss) via the MClD computer imaging analysis system (Imaging Research, St. Catharines, Ontario, Canada). Neurite outgrowth was quantified using a software program developed in our . Iaboratory that includes measurements of the number, length, and diameter of branches (27) . Fifty TuJl-positive cells per group were measured, and all measurements were performed by experimenters blinded to each culture condition.
Statistical Analysis-One-way analysis of variance followed by Student-Newman-Keuls test was performed. The data were presented as means ± S.E. A value of p < 0.05 was taken as signitlcant.
RESULTS

CEPO Induces Proliferation and Differentiation of Neural
Progenitor Cells-To examine the effect of CEPO on adult neural progenitor cells, we employed a neurosphere assay that has been widely used for investigating the biology of neural progenitor cells (24, 28 -31) . When neural progenitor cells harvested from the SVZ of the adult mouse were plated at a density of20 cells/ pJ on the non-adhesive culture surface in the reduced growth medium (10 ng/ml ofbFGF and 10 ng/m l ofEGF), these 4 cells/ml) in medium without the growth factors for 7 days, these cells differentiated into TuJlpositive (Fig. lC) , a marker of immature neurons, GFAP-positive, a marker of astrocytes (Fig. ID) , and 04-positive cells, a marker of oligodendrocytes (Fig. IE) . However, NeuN-positive cells, a marker of mature neurons, were not detected until 14 days in culture, which is consistent with published studies (32) . These data indicate that SVZ cells have the capacity of selfrenewal and undergo multilineage differentiation, characteristics of neural progenitor cells (33) .
We then determined whether CEPO promotes neural progenitor cell proliferation. Single SVZ cells were cultured in the reduced growth medium containing CEllO (0, 1, 10, 100 ng/ml) . Exposure of single SVZ cells to CEPO (10 and 100 ng/ml) resulted in a significant (p < 0.05) increase in the number and size of primary neurospheres (Fig. 2, B, G, and H) compared with that in the control group (Fig. 2, A, G, and H) . We further measured the number of the secondary neurospheres in which the CEPO-treated neurospheres were dissociated and reseeded at 1 X 10 4 cells/ml in the reduced growth medium. Compared with the control group, the number of the secondary neurospheres derived from the CEPO-treated (10 ng/ml) group was significantly (p < 0.05) increased (459 ± 14%, n = 8 versus (Fig. 3, A and C) . The increase of TuJl -positive cells could reflect a decrease of cell death. To address the possibility that CEPO may act as a survival factor for neural progenitor cells, we measured the number of terminal deoxynudeotidyltransferase -mediated dUTP nick end-labeling (TUNEL) -positive cells and found that the number ofTUNELpositive cells in the CEPO group (12 ± 1.2%, n = 4) was not significantly different from the number in the control group (11 ± 1.1%, n = 4) . These data suggest that CEPO selectively enhances neural progenitor cell differentiation into neurons.
To examine whether CEPO enhances neurite outgrowth, neurite outgrowth was quantified by measuring the length and number of branches extending from TuJ1-positive cell soma. In the control group, TuJl-positive cells exhibited a few short branches (Fig. 4E) . However, TuJ I-positive cells exhibited complex branching patterns when neural progenitor cells were incubated with CEPO (Fig. 4F) CEPO significantly (p < 0.05) increased the number ofBrdUrdpositive cells (Fig. 2 , E and J) and the number of BrdUrd-and nestin-positive cells (Fig. 2 , J and J(), suggesting that increases of number and size of neurospheres result from an increase of progenitor cells but are not induced by an increase of cell aggregation. In parallel, time-lapse microscopic analysis revealed that 15 cells that migrated out of the neurosphere were dividing in the CEPO (10 ng/ml) group during a 20-h experimental period, whereas only 4 dividing cells were detected in the control group at the same time period. Collectively, these results demonstrate that CEPO augments neural progenitor cell proliferation. We next determined the effect of CEPO on neural progenitor cell differentiation. Single cells dissociated from neurospheres were reseeded on laminin-coated glass coverslips (2.5 X 10 4 cells/ml) and treated with CEPO (0, 1, 10, 100 ng/ml) for 7 days in differentiation medium without the growth factors . Treatment with CEPO (10 and 100 ng/ml) significantly increased the number of TuJl-positive (Fig. 3 , Band C) and MAP2-positive (3.8 ± om %, 11 = 8 in CEPO 10 ng/ml versus 1.7 ± 0.04%, n = 0.05) increased the number and length of branches (Fig. 4 , J and J(), suggesting that CEPO promotes neurite outgrowth.
We then measured the effect of CEPO on SVZ cells harvested from ~EPOR mice. Treatment with EPO (10 units/ml) significantly (p < 0.05) increased the number ofTuJl-positive cells in neural progenitor cells derived from wild-type mice (4 ± 0.32%, n = 8 versus 2 ± 0.2%, n = 8, in control) but did not increase the number ofTuJ I-positive cells in ~EPOR neural progenitor cells (3 ± 0.5%, n = 8 versus 3 ± 0.3%, n = 8 in control), which is consistent with our previous studies (6, 27) . However, treatment of ~EPOR neural progenitor cells with CEPO (10 ng/ml) significantly (p < 0.05) increased the number of TuJl -positive cells (5 ± 0.5%, n = 8) compared with the number in the control group (3 ± 0.3%, n = 8). These results suggest that EPOR is not required for CEPO-enhanced neurogenesis.
The ShhlGlil Signaling Pathway Regulates the Effect ojCEPO on Neural Progenitor Cell Prolif eration and Differentiation-The
Shh/Glil signaling pathway is required for regulating neurogenesis in the adult rodent brain (20, 34) . To determine whether CEPO induces Shh/Gli1 signaling activation, we group (379 ± 16.9, n = 8). These data are consistent with findings that EGF at lower concentration has a synergistic effect with Shh in the control of proliferation of SVZ neural progenitor cells (16) . To test whether Shh signaling is necessary for CEPO to promote proliferation and differentiation of neural progenitor cells, we treated neural progenitor cells with CEPO in the presence of the Shh antagonist cyclopamine. Application of cyclopamine (5 fLM) abolished the ability of CEPO to induce pte and Glil expression but did not suppress CEPO-induced Shh expression (Fig. 5, A and B) . In addition, cyclopamine significantly reduced the numbers of CEPO -increased BrdUrdpositive (Fig. 2, F and 1) and TuJ I-positive (Fig. 4, D and 1) cells compared with the numbers in the control group. Furthermore, cyclopamine blocked CEPO-induced neurite outgrowth (Fig. 4, 
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H, J, and /() . These data indicate that the Shh/Glil pathway regulates CEPO-enhanced neural progenitor cell proliferation and differentiation. To directly examine the effect of Shh on neural progenitor cell proliferation and differentiation, we measured the number of BrdUrd-and Tu]1-positive cells after treatment with Shh-N. At a concentration of 5 ng/ml EGF, Shh has a synergistic effect on neural progenitor cells (16) . Therefore, SVZ neural progenitor cells were cultured in the growth medium containing EGF (5 ng/ml) with or without Shh-N (100 ng/nl) for 7 days. Shh-N treatment led to a significant (p < 0.05) increase of BrdUrdpositive cells from 61 ± 2% in the control group to 73 ± 2%. In addition, Shh-N treatment substantially increased the number of TuJ1-positive cells in a dose-dependent manner, with maximal increases at a dose of 1,000 ng/ml (11 ± 0.3%, n = 8 for 100 ng/ml and 16 ± 0.7%, n = 8 for 1,000 ng/ml versus 2 ± 0.2%, n = 8 in control) when neural progenitor cells were cultured in the differentiation medium . These data indicate that Shh induces neural progenitor cell proliferation and differentiation, which is consistent with published results (35) . .. (Fig.  6 , Band C) and protein (Fig. 6, D and E) levels at 1 and 7 days in vitro, respectively, compared with levels in the control group. We then tested whether an increase in Mashl regulates CEPO-promoted neuronal differentiation. We constructed siRNA cassettes against mouse Mashl (Fig. 7A, siRNA (Fig. 7, F and G) . Furthermore, treatment with CEPO for _ . . ---. . . . (Fig. 4 , G, J, and K) . These data suggest that
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Mashl mediates CEPO-promoted neuronal differentiation. In addition to Mashl, CEPO increased Ngnl mRNA levels (2.2 ± 0.02 versus 1.0 ± 0.08 in control group), another pto-neuronal bHLH transcription factor (27) . Expression of Mas hl can be regulated by Shh, bone morphogenetic proteins, and the Wnt pathway (37-4.0). Our real-time RT -PCR analysis showed that CEPO did not alter mRNA levels of BMP2 (1.12 ± 0.6) and Wnt3a (1.5 ± 0.5) in neural progenitor cells compared with levels in the control group (1.0 ± 0.1) . T hus, the Shh/Glil signaling pathway could be a potential interm ediate signal in regulating CEPOpromoted neuronal differentiation. If Shh is the intermediate signal between CEPO and Mashl signaling, then we would expect that blockage of Shh signaling would abolish CEPO-up-regulated Mashl expression and consequently inhibit CEPO-promoted neuronal differentiation. Real-time RT -PCR and Western blot analysis revealed that incubation of neural progenitor cells with CEPO (10 ng/ml) in the pres- ; . .
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pressed CEPO-promoted neuronal differentiation. These data indicate that CEPO enhances in vitro neurogenesis which is mediated by the Shh signaling pathway and that Mashl is a downstream target of the 5hh signaling pathway and regulates CEPO -enhanced neuronal differentiation. 
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Using a commonly employed in vitro assay, we show that the treatment of neural progenitor cells derived from the 5VZ of adult mouse with CEPO substantially increased the numbers of proliferative cells and neurons but did not increase astrocytes. These data demonstrate for the first time that in addition to its neuroprotective effect, CEPO augments neural progenitor cell proliferation and selectively promotes neural progenitor cell differentiation into neurons. The Shh signaling pathway orchestrates neurogenesis in the adult brain (16, 34) . 5hh acts as a mitogen in cooperation with EGF to regulate proliferation of neural stem cells in adult SVZ (41) . Exogenous 5hh increases neurogenesis in the 5VZ, whereas blockage of Shh signaling in adult mice diminishes expression of Glil and reduces SVZ cell proliferation (16) . Using Glil -CreER'j'2 mice, in which an inducible Cre recombinase (CreERT2) is expressed from Glil, Ahn and Joyner (20) have recently demonstrated in vivo that Shh regulates neural stem and progenitor cells in the SVZ and the subgranular zone of adult mouse. Here, we show that CEPO activated the 5hh signaling pathway with low doses of EGF and bFGF but CEPO on its own is not sufficient to up-regulate the 5hh pathway genes. The effects of CEPO on the 5hh pathway are specific, as coincubation of neural progenitor cells with CEPO and cyclopamine, a pharmacological inhibitor of the 5hh pathway, abolished CEPO-induced Glil expression and conseence of cyclopamine (5 J.1.M) significantly attenuated CEPOincreased Mashl mRNA and protein levels (Fig. 6, B-E) and suppressed CEPO-increased TuJl-positive cells (Fig. 4, D  and I ). In addition, blockage of Glil , the effector of Shh signaling, with siRNA-Glil significantly attenuated CEPO-upregulated Mashl expression (0.8 ± 0.03 versus 2.0 ± 0.1 in CEPO group) . To examine whether 5hh signaling is sufficient to induce Mashl expression, n eural progenitor cells were treated with 5hh-N (100 ng/ml) and assayed for Mashl expression. Treatment with 5hh-N led to a robust increase in Mashl and Glil expression compared with the control group (Fig. 8, A and B) . Double immunostaining revea led that Mashl -immunoreactive cells were Gli -positive (Fig. 8, C-F) . These results indicate that Shh signaling is sufficient to promote Mashl expression in the absence of CEPO. Together,
